首页> 外国专利> METHOD FOR TESTING ADEQUACY OF PROPHYLAXIS AND THERAPUTIC AGENT FOR ACUTE CARDIAC INFARCTION

METHOD FOR TESTING ADEQUACY OF PROPHYLAXIS AND THERAPUTIC AGENT FOR ACUTE CARDIAC INFARCTION

机译:急性心肌梗死的PROPROLAXIS和治疗剂的适当性测试方法

摘要

PURPOSE:To enhance testing accuracy and to make the test economical by imparting pressure into the aorta of the extracted heart of a small mammalian animal to which calcium setting calcium medicine and trigger medicine are dosed, injecting trigger medicine, and perfusing the medicine through a coronary. CONSTITUTION:Calcium setting calcium medicine and medicine to be checked are injected into a small mammal animal. The heart of the animal is extracted. Pressure is applied in the aorta of the heart, and trigger medicine is injected and perfused through a coronary. Thus, the reaction of the cardiac muscle of the heart is checked. As the calcium setting calcium medicine, the aqueous solution of calcium which is hardly harmful by itself, i.e. has less toxicity, is used. As the calcium medicine such as this, aqueous solution of calcium chloride is preferable. The trigger medicine is selected among medicines which build up muscle contraction. For example, any of calcium chloride, adrenaline and isoproterenol can be dosed independently as the trigger medicine.
机译:目的:通过向哺乳动物小型动物的主动脉施加压力来提高测试准确性并使测试更加经济,在该小型哺乳动物的主动脉中已注入了钙固定钙药物和触发药物,注射了触发药物,并通过冠状动脉灌注了该药物。组成:钙定型钙药物和要检查的药物被注射到一只小型哺乳动物中。提取动物的心脏。在心脏的主动脉中施加压力,并通过冠状动脉注射和灌注触发药物。因此,检查了心脏的心肌反应。作为钙定型钙药物,使用本身几乎无害即毒性较小的钙水溶液。作为这样的钙药,优选氯化钙的水溶液。触发药物选自会增强肌肉收缩的药物。例如,氯化钙,肾上腺素和异丙肾上腺素中的任何一种都可以独立剂量作为触发药物。

著录项

  • 公开/公告号JPH03214055A

    专利类型

  • 公开/公告日1991-09-19

    原文格式PDF

  • 申请/专利权人 TAKEISHI MAKOTO;KANEKO NOBORU;

    申请/专利号JP19890188350

  • 发明设计人 TAKEISHI MAKOTO;

    申请日1989-07-20

  • 分类号G01N33/15;

  • 国家 JP

  • 入库时间 2022-08-22 06:05:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号